Advertisement
Of those aged younger than 21 years with deaths associated with severe acute respiratory syndrome coronavirus 2

Characteristics ID’d for Under 21s With SARS-CoV-2-Linked Deaths

0
Teens and young adults, those with underlying medical conditions overrepresented among decedents
Factor V activity is significantly increased in patients with severe COVID-19

Factor V Activity Significantly Increased in Severe COVID-19

0
Rates of DVT/PE significantly higher for patients with COVID-19 and elevated factor V activity
In a sign that Americans are becoming more wary about the safety of a COVID-19 vaccine

Poll: Most Americans Do Not Trust Trump’s COVID-19 Vaccine Comments

0
More than half of adults say they do not trust the president's vaccine comments
Two of three planned adaptive phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19 have launched

NIH Launches Clinical Trials of Antithrombotics for COVID-19

0
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients
For the first time in six months

Canada Reports No New COVID-19 Deaths for First Time in Six Months

0
As of Saturday, there had been 137,676 COVID-19 cases and 9,214 deaths from the illness in Canada
Oxford University has announced that final-stage testing of a COVID-19 vaccine it is developing with drug maker AstraZeneca will restart following a pause last week after a serious side effect showed up in a volunteer.

AstraZeneca COVID-19 Vaccine Trial Restarts

0
Trial was halted after a suspected adverse reaction in a patient
A study to assess the effectiveness of two experimental COVID-19 vaccines when they are inhaled

Effectiveness of Inhaled COVID-19 Vaccines to Be Studied

0
Trial will test responses of 30 adults when they inhale vaccine droplets in their mouths
Using an anti-inflammatory medicine along with the antiviral drug remdesivir appears to shorten COVID-19 patients' recovery time

Baricitinib May Shorten Recovery Time in Hospitalized COVID-19 Patients

0
Adding anti-inflammatory drug to remdesivir seems to shorten time to hospital discharge
Pneumothorax is being reported as a complication of COVID-19

Pneumothorax Reported as Complication of COVID-19

0
Higher incidence seen among men; survival at 28 days lower for those 70 years of age or older
There was an excess of patients with cough and respiratory complaints identified at a large U.S. health system from December 2019 to February 2020

COVID-19 Suspected for Surge in Medical Visits at End of 2019

0
Excess seen for visits with cough in outpatient clinics, ED; hospitalizations with acute respiratory failure